MGV Vaccine

**Semantic type:** Immunologic Factor|Pharmacologic Substance

**Definition:** A vaccine that contains the GM2 and GD2 antigens separately coupled to the carrier protein Keyhole Limpet Hemocyanin and mixed with QS-21 adjuvant (an immune system stimulant), designed to stimulate a patient's immune system to control or eradicate residual cancer cells after surgery, radiation or chemotherapy. (NCI)

**Synonyms:** - BMS 248967 - GM2/GD2 gangliosides-KLH Vaccine